EMA — authorised 13 April 2022
- Marketing authorisation holder: ASTELLAS PHARMA EUROPE B.V.
- Status: approved
🇪🇺 Padcev in European Union
EMA authorised Padcev on 13 April 2022
Marketing authorisation
Padcev in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Padcev approved in European Union?
Yes. EMA authorised it on 13 April 2022.
Who is the marketing authorisation holder for Padcev in European Union?
ASTELLAS PHARMA EUROPE B.V. holds the EU marketing authorisation.